Spectranetics Corporation Selects Clinipace Inc. Worldwide to Manage Cardiovascular Device Clinical Study

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Spectranetics Corporation (Nasdaq: SPNC), a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal cardiovascular device clinical study that will serve as the basis for 510(k) notice submission.